CCI study: Anti-platelet, anticoagulant treatment warranted in PCI patients with AF

06/30/2013 | Healio

A combination of anti-platelet and anticoagulant therapy is appropriate for atrial fibrillation patients who are undergoing PCI to mitigate stroke risk, according to a prospective, multicenter study reported in Catheterization and Cardiovascular Interventions. The study also found that vitamin K antagonist therapy should not be discontinued prior to PCI.

View Full Article in:

Healio

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
White Plains, NY
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ